How Pfizer’s $43 billion acquisition of Seagen could impact the biotech industry in Seattle by Charlotte Schubert on March 13, 2023March 17, 2023 at 10:43 pm Biopharma acquisitions often come with layoffs and lab shutdowns as smaller companies get absorbed. Whether that happens to Seagen is a big question that will impact the Seattle-area biotech community.… Read More